CTY insider buying and SEC filings, explained
City Therapeutics, Inc. · CIK 2143850
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$6.1M
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 19, 2026 | Purchase (code P) | Keith Crandell (10% owner) bought 170,000 shares indirectly (by entity) at $18.00 ($3.1M), reported as a purchase (code P). Holdings by entity up 1% to 13,692,507 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 5 other reporting owners. | SEC filing Filed Oct 19, 2026, 5:38 PM ET |
| Oct 19, 2026 | Purchase (code P) | Robert Nelsen (Director and 10% owner) bought 170,000 shares indirectly (by entity) at $18.00 ($3.1M), reported as a purchase (code P). Holdings by entity up 1% to 13,692,507 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 19, 2026, 5:37 PM ET |
7 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$6.1M in purchases since Oct 19, 2026 · Purchases traded Oct 19, 2026 to Oct 19, 2026 · Active
| Insider | Value | Traded | Source |
|---|---|---|---|
| Robert Nelsen (Director) | $3.1M | Oct 19, 2026 | SEC filing |
| Keith Crandell (10% owner) | $3.1M | Oct 19, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CTY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.